Firebrick Pharma Ltd has released a press release.
Firebrick Secures Investment from Philippines Partner
Filed with ASX ·
6ix hasn’t read this filing yet.
Firebrick Pharma Limited on 6ix
Story so far
Earlier from Firebrick Pharma
- Firebrick receives $250,000 R&D Tax Incentive
- Appendix 4E and Annual Report 30 June 2025
- Firebrick Secures $1.4 million via Placement
- License Agreement for Singapore, Malaysia, Brunei, Mauritius
- June 2025 Quarterly Activity Report & Appendix 4C
Later from Firebrick Pharma
- September 2025 Quarterly Activity Report & Appendix 4C
- Firebrick announces new product Nasodine Throat Spray
- Nasodine Throat Spray Product Launch in Singapore
- December 2025 Quarterly Activity Report & Appendix 4C
- Appendix 4D & Half-Year Financial Report to 31 December 2025
Follow Firebrick Pharma into a list and get an email when it puts out news.
Follow Firebrick Pharma